Abstract
Recent studies have shown that brief exposure to an elevated plus-maze (EPM) produces non-opioid antinociception in male mice. The present experiments were designed to assess the effects of diazepam on this phenomenon. When acutely administered, low doses (0.5–1.0 mg/kg) of diazepam failed to produce an anxiolytic profile and exerted rather inconsistent effects on EPM-induced elevations in tail-flick latencies. In EPM-experienced mice, chronic treatment with higher doses of diazepam (2–4 mg/kg, 8 days) produced a weak anxiolytic action and inhibited the early phase of EPM antinociception only. However, in EPM-naive mice, 8-day diazepam pretreatment exerted a marked anxiolytic effect and completely eliminated the antinociceptive response to the maze. Together, these data support the view that anxiety is a key factor in certain forms of adaptive pain inhibition and suggest a possible mediational role for benzodiazepine receptors. Our findings also show that prior exposure to the EPM, rather than chronic handling/injection, greatly reduces the anti-anxiety effect of diazepam. Furthermore, since re-exposure to the maze, perse, decreased time spent on the open arms and central platform, a shift in behavioural baseline (“retest anxiogenesis”) may have contributed to the weak behavioural effects of diazepam in test-experienced animals. Importantly, as chronic treatment with diazepam did not influence this anxiogenic-like retest profile, our data suggest that a single prior experience of the EPM may radically alter the nature of the anxiety reaction provoked by this test.
Similar content being viewed by others
References
Amir S (1986) Catalepsy induced by body pinch: relation to stress-induced analgesia. Ann NY Acad Sci 467:226–237
Amit Z, Galina ZH (1986) Stress-induced analgesia: adaptive pain suppression. Physiol Rev 66:1091–1120
Baldwin HA, File SE (1988) Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull 20:603–606
Benjamin D, Lal H, Meyerson LR (1990) The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci 47:195–203
Blanchard DC, Blanchard RJ, Tom P, Rodgers RJ (1990) Diazepam changes risk assessment in an anxiety/defense test battery. Psychopharmacology 101:511–518
Boix F, Fernandez Tereul A, Escorihuela RM, Tobena A (1990) Handling-habituation prevents the effects of diazepam and alprazolam on brain serotonin levels in rats. Behav Brain Res 36:209–215
Bolles RC, Fanselow MS (1980) A perceptual-defensive recuperative model of fear and pain. Behav Brain Sci 3:291–323
Brett RR, Pratt JA (1990) Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze. Eur J Pharmacol 178:135–138
Critchley MAE, Handley SL (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502–506
Drugan RC, Ryan SM, Minor TR, Maier SF (1984) Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. Pharmacol Biochem Behav 21:749–754
Fanselow MS (1986) Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann NY Acad Sci 467:40–54
Fanselow MS, Helmstetter FJ (1988) Conditioned analgesia, defensive freezing and benzodiazepines. Behav Neurosci 102:233–243
File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plusmaze. Psychopharmacology 100:281–282
File SE, Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of “one trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze
Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of “fear”-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5
Itoh J, Nabeshima T, Kameyama T (1990) Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101:525–532
Jackson RL, Maier SF, Coon DJ (1979) Long-term analgesic effects of inescapable shock and learned helplessness. Science 206:91–93
Johnston AL, File SE (1988) Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiatry Res 25:81–90
Kaesermann H-P (1986) Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology 89:31–37
Kavaliers M, Innes DGL (1988) Scent-induced non-opioid analgesia in the deer mouse,Peromyscus maniculatus: involvement of benzodiazepine systems. Physiol Behav 42:131–135
Kelly DD (ed) (1986) Stress-induced analgesia, vol 467. NY Academy Sciences, New York
Kinsheck JB, Watkins LR, Mayer DJ (1984) Fear is not critical to classically-conditioned analgesia: the effects of periaqueductal gray lesions and administration of chlordiazepoxide. Brain Res 298:33–44
Lee C, Rodgers RJ (1990) Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology 102:507–513
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Marriott AS, Smith EF (1972) An analysis of drug effects in mice exposed to a simple novel environment. Psychopharmacologia 24:397–406
Montgomery KC (1958) The relation between fear induced by novelty stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254–260
Morato S, Castrechini P (1989) Effects of floor surface and environmental illumination on exploratory activity in the elevated plus-maze. Braz J Med Biol Res 22:707–710
Moser P (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99:48–53
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529
Rago L, Kiivet R-A, Harro J, Pold M (1988) Behavioural differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 337:675–678
Rodgers RJ, Randall JI (1986a) Acute non-opioid analgesia in defeated male mice. Physiol Behav 36:947–950
Rodgers RJ, Randall JI (1986b) Resident's scent: a critical factor in acute analgesic reaction of defeat experience in male mice. Physiol Behav 37:317–322
Rodgers RJ, Randall JI (1987a) Benzodiazepines ligands, nociception and “defeat” analgesia in male mice. Psychopharmacology 91:305–315
Rodgers RJ, Randall JI (1987b) Are the analgesic effects of social defeat mediated by benzodiazepine receptors? Physiol Behav 41:279–289
Rodgers RJ, Randall JI (1987c) Defensive analgesia in rats and mice. Psychol Rec 37:335–347
Rodgers RJ, Randall JI (1988a) Environmentally-induced analgesia: situational factors, mechanisms and significance. In: Rodgers RJ, Cooper SJ (eds) Endorphins, opiates and behavioural processes. Wiley, Chichester, pp 107–142
Rodgers RJ, Randall JI (1988b) Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands. Psychopharmacology 96:45–54
Rodgers RJ, Shepherd JK (1989a) 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), inhibits non-opioid analgesia in defeated male mice: influence of route of administration. Psychopharmacology 97:163–165
Rodgers RJ, Shepherd JK (1989b) Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone. Psychopharmacology 99:374–380
Rodgers RJ, Shepherd JK (1990a) Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice. Neuropharmacology 29:17–23
Rodgers RJ, Shepherd JK (1990b) Stereospecific inhibition of non-opioid defeat analgesia in male mice by MDL 72832, a selective 5-HT1A receptor agonist. Eur J Pharmacol 182:581–585
Shepherd JK, Rodgers RJ (1989) Acute and chronic effects of the triazolobenzodiazepine, alprazolam, on defeat and analgesia evoked by conspecific attack in male mice. Behav Pharmacol 1:75–84
Simon P, Soubrie P (1979) Behavioural studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs. Mod Probl Pharmacopsychiatry 14:99–143
Soderpalm S, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259–265
Taukulis HK, Goggin CE (1990) Diazepam-stress interactions in the rat: effects on autoanalgesia and a plus-maze model of anxiety. Behav Neural Biol 53:205–216
Tricklebank Md, Curzon G (eds) (1984) Stress-induced analgesia. Wiley, Chichester
Willer C, Ernst M (1986) Somatovegetative changes in stress-induced analgesia in man: an electrophysiological and pharmacological study. Ann NY Acad Sci 467:256–272
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodgers, R.J., Lee, C. & Shepherd, J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106, 102–110 (1992). https://doi.org/10.1007/BF02253596
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02253596